mammography trial

High-profile, $100M mammography trial touts new enrolment milestone

Source: The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has recently reached 65,000 participants. Which surpasses the halfway mark toward its current goal of 128,905. Organisers said on Friday that enrolment had doubled over the last year and a half, with Black women accounting for more than 20% of enrolment.

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. We aim to foster a culture of excellence through collaboration with industry experts and thought leaders to deliver better outcomes.